GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zim Corp (OTCPK:ZIMCF) » Definitions » ROE % Adjusted to Book Value

Zim (ZIMCF) ROE % Adjusted to Book Value : -49.66% (As of Sep. 2021)


View and export this data going back to 2003. Start your Free Trial

What is Zim ROE % Adjusted to Book Value?

Zim's ROE % for the quarter that ended in Sep. 2021 was -28.80%. Zim's PB Ratio for the quarter that ended in Sep. 2021 was 0.58. Zim's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2021 was -49.66%.

Zim ROE % Adjusted to Book Value Historical Data

The historical data trend for Zim's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zim ROE % Adjusted to Book Value Chart

Zim Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -81.70 -50.55 550.33 -2.65 -9.15

Zim Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -51.59 -19.92 205.52 -35.64 -49.66

Competitive Comparison of Zim's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Zim's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zim's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zim's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Zim's ROE % Adjusted to Book Value falls into.


Zim ROE % Adjusted to Book Value Calculation

Zim's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2021 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-6.50% / 0.71
=-9.15%

Zim's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2021 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-28.80% / 0.58
=-49.66%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zim ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Zim's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Zim (ZIMCF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zim Corp (OTCPK:ZIMCF) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
MAPT FSSN TGHI FDBL WDDD GAHC ABQQ VBIXD MCCX VRTC CRM INTU XTER:SAP NOW TEAM SNOW UBER XPAR:DSY CDNS ADSK
Traded in Other Exchanges
N/A
Address
20 Colonade Road, Suite 200, Ottawa, ON, CAN, K2E 7M2
Website
https://www.zim.biz
Zim Corp has sold its operations and is currently focused on biomedical research. The company focused all of its resources on developing intellectual property and advancing research and development in the areas of new synthetic drugs and immunotherapies. It generates geographic revenue from Canada.
Executives
John Anthony Chapman officer: Chief Financial Officer 30 HOLITZNER WAY OTTAWA A6 K2G 6V6
Filippo Scavo officer: VP Business Development 1140 STANTON ROAD OTTAWA A6 K2C 3C7
Roberto Campagna officer: VP Retail Sales
Marlen Cowpland 10 percent owner
Bill Parisi officer: VP of Business Development 1530 REINDEER WAY GREELY ONTARIO CANADA D5 K4P1N1
Favero Roderio De officer: VP of Bus Dev - Brazil RUA NILZA MEDEIROS MARTINS 200, BLOCO 4,APR 114 SAO PAULO, BRAZIL D5 05628-010
Donald Gibbs director 239 CHICAGE TRAIL MEDFORD LAKES NJ 08088
Cowpland Michael C J director, 10 percent owner, officer: Pres &, other: CEO C/O ZIM CORP 20 COLONNADE ROAD OTTAWA ONTARIO A6 K2E 7M6
Steven Houck director C/O ZIM CORP 20 COLONNADE ROAD OTTAWA, ONTARIO A6 K2E 7M6
James Stechyson director C/O ZIM CORP 20 COLONNADE ROAD OTTAWA, ONTARIO A6 K2E 7M6
Jennifer North officer: CFO, other: Secretary C/O ZIM CORP 20 COLONNADE ROAD OTTAWA ONTARIO A6 K2E 7M6
Charles Saikaley director C/O ZIM CORP 20 COLONNADE ROAD OTTAWA ONTARIO A6 K2E 7M6
Tony Davidson officer: Chief Technology Officer 74 KNUDSON DRIVE KANATA A6 K2K 2L5
Denise Batson 10 percent owner C/O ZIM CORP 20 COLONNADE ROAD, SUITE 200 NEPEAN A6 K2E 7M6

Zim (ZIMCF) Headlines

From GuruFocus

ZIM Announces Financial Results For the Second Quarter of 2020

By PRNewswire PRNewswire • 08-19-2020

ZIM Integrated Shipping Services Ltd. - Announcement of the Results of a Tender Offer

By PRNewswire PRNewswire • 10-13-2020

ZIM to Launch a new Mexico - Tampa Shuttle Service in December

By PRNewswire PRNewswire • 11-13-2020

ZIM Announces Changes in Its Board

By PRNewswire PRNewswire • 10-15-2020